The Independent reported on Saturday that the world's largest pharmaceutical companies are facing a corruption investigation in the US over claims that the hospitality lavished on those who prescribe their treatments could constitute bribery.
Alistair Dawber of the Independent writes:
Britain's two biggest drug groups, GlaxoSmithKline (GSK) and AstraZeneca, are among those facing the investigation, which is being carried out jointly by the Department of Justice (DoJ) and Securities and Exchange Commission (SEC). The investigation is thought to centre around allegations that drugs companies might have contravened the Foreign Corrupt Practices Act (FCPA), which limits their ability to spend on such "soft' inducements" as hospitality, charitable donations and other non-business activities.
The list of the companies under investigation contains many of the global pharma industry's biggest names: Pfizer, Bristol-Myers Squibb and Eli Lilly are among those under the spotlight.
The DoJ is looking into claims that the industry has for years ignored obligations under anti-bribery legislation, and that the situation is so stark, some of the hospitality extended to those that buy treatments could amount to bribery.
The probe is into activities outside the US. If found guilty, the industry could face fines totalling millions of dollars.
Both GSK and AstraZeneca acknowledged the investigation yesterday. It is understood that GSK received a letter at the end of April, which said that the DoJ was making preliminary inquiries under the FCPA.
"GSK confirms that investigations by the US Department of Justice and the Securities and Exchange Commission regarding the sales and marketing of pharmaceutical products outside of the USA have commenced," the group said in a statement. "These inquiries relate to the USA Foreign and Corrupt Practices Act. GSK has been contacted by these agencies in this context and is helping with the preliminary inquiries."
This news comes on the back of a recent twenty minute documentary that was aired on Aljazeera.
The documentary investigates how drug companies put profits before patients and focuses on Johnson & Johnson's Risperdal and GlaxoSmithKline's Avandia.
Pay particular attention to Joseph Biederman [15.26]. Biederman is a psychiatrist at Harvard Medical School. Footage in this film shows Biederman speaking under oath. He is asked, "Professor, what rank are you?"
BIEDERMAN: Full Professor
"What's after that?"
"Did you say God?"
The most worrying thing about Biederman's claim is that it appears as though he actually believes in what he is saying.
The documentary also highlights how Risperdal has allegedly caused many young boys to grow breasts.
It's a must watch.
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING